Argonaut Therapeutics Company

Argonaut Therapeutics is a precision therapeutics company that was established to develop epigenetically-acting drugs which target abnormal arginine methylation in cancer. The company was founded on pioneering research from the University of Oxford, UK. Argonaut strives to develop a new class of precision cancer medicines which target the enzymes responsible for abnormal arginine methylation in cancer.
Technology: Drug Discovery
Industry: Personalized Medicine
Headquarters: Oxford, Oxfordshire, United Kingdom
Founded Date: Undisclosed
Employees Number: Undisclosed
Funding Status: N/A

Visit Website
enquiries@argonauttherapeutics.co.uk
Register and Claim Ownership